We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 101.00
Bid: 101.50
Ask: 102.00
Change: -4.50 (-4.27%)
Spread: 0.50 (0.493%)
Open: 105.00
High: 105.00
Low: 101.00
Prev. Close: 105.50
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of CEO and Chairman Succession

4 Oct 2019 14:05

RNS Number : 8649O
McBride PLC
04 October 2019
 

4 October 2019

McBride plc

 

 

Appointment of Chief Executive Officer and Chairman Succession

 

 

McBride plc, the leading European manufacturer and supplier of Contract Manufactured and Private Label products for the domestic Household and professional cleaning/hygiene markets, today announces the following Board changes.

 

Chief Executive Officer

 

The Board is pleased to announce the appointment of Ludwig de Mot as Chief Executive Officer. He will join the Board of McBride plc on 1 November 2019 and will also join the Nomination Committee.

 

Ludwig, a Belgian national, joins from ArcelorMittal where he served as President and Chief Executive Officer of its Canadian mining operations. Prior to ArcelorMittal, Ludwig spent 12 years in senior executive positions at the Lhoist Group, the global minerals and lime producer, including President and Chief Executive Officer of its European, North American and Asian operations, where he successfully grew the business through a combination of organic growth, restructuring and selective acquisitions. Ludwig worked for 10 years in senior management roles across Europe with SCA Packaging, and in his early career held positions at Schaeffler and Saint-Gobain.

 

Ludwig is currently a non-executive director of VPK Packaging Group, the privately-owned Belgian packaging company.

 

There is no other information required to be disclosed pursuant to paragraph 9.6.13 R of the Listing Rules.

 

John Coleman, Chairman, commented:

 

"The Board is delighted to welcome Ludwig to McBride. His commercial and operational expertise will be highly complementary to our team and he brings a wealth of international experience in manufacturing and selling in many different geographies. The Board very much looks forward to working with him as it continues to execute its strategy and create value for shareholders."

 

With effect from Ludwig's commencement date, Chris Smith, currently Interim Chief Executive Officer, will resume his role as Chief Financial Officer.

 

Chairman succession

 

Following the appointment of Ludwig as the new Chief Executive, John Coleman has decided not to seek re-election at the AGM on 22 October 2019 and will stand down as a Director and Chairman following the AGM.

 

John Coleman said "Following the successful recruitment of the new Chief Executive I believe this is the right time for me to step down and allow a new team to take the Company through the next phase of its development."

 

As a consequence, Resolution 5 as set out in the AGM Notice is now redundant. A further announcement on John's succession will be made in due course.

 

Enquiries to:

 

McBride plc

Chris Smith, Interim Chief Executive

0161 203 7575

 

FTI Consulting

Ed Bridges, Nick Hasell

020 3727 1017

 

 

Note to Editors

 

Mr de Mot's annual remuneration package, which is in line with the Company's shareholder approved Remuneration Policy, will include the following:

 

·; base salary of £500,000;

·; bonus opportunity of up to 100% of base salary, pro-rated from his joining date for the first financial year of his appointment;

·; an award of up to a maximum of 125% of base salary under the Company's Long Term Incentive Plan 2014 (LTIP). This will vest based on performance over a three year performance period as assessed by the Remuneration Committee, against TSR and eps targets. The award will also be subject to a two year holding period;

·; Pension payments (cash allowance or contribution) equal to 8% of base salary, plus other standard contractual benefits.

·; A non-pensionable payment of up to a maximum of £25,000 over a twelve month period for temporary accommodation and up to a further £25,000 in relation to relocation expenses and costs in line with relevant tax rules.

 

The Company has also agreed the following buy-out arrangements to compensate for the forfeiture of incentive compensation from Mr de Mot's current employment. The recruitment remuneration policy approved by shareholders sets out how to determine the buy-out of outstanding incentives from the previous employer, namely, that the value of any buy-out payments should be no higher than the expected value of the forfeited arrangements. In line with that policy, the buy-out of current share based incentives is either through restricted shares and performance shares (or a blend of both), dependent upon the basis of the incentives being forfeited. The timing of payments will be no earlier than the incentives forfeited.

 

Mr de Mot will, on the date of joining, receive a one off restricted share award worth £125,000, which will vest on the first anniversary of his date of joining subject to Mr de Mot being in the Company's employment and notice not having been given or received to terminate employment.

 

All net shares vesting must be retained until the Company's Share Ownership Guidelines for Executive Directors have been met.

 

Full details will be disclosed in the relevant Directors' Remuneration Report.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFIVIFLSIIA
Date   Source Headline
8th Apr 202411:24 amRNSHolding(s) in Company
8th Apr 202411:22 amRNSHolding(s) in Company
5th Apr 20249:53 amRNSHolding(s) in Company
28th Mar 20243:20 pmRNSDirector/PDMR Shareholding
25th Mar 20241:52 pmRNSDirector/PDMR Shareholding
13th Mar 20247:00 amRNSCapital Markets Day
28th Feb 20242:30 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSTrading Update
13th Dec 20231:47 pmRNSDirector/PDMR Shareholding
20th Nov 20235:55 pmRNSDirector/PDMR Shareholding
20th Nov 20235:39 pmRNSResult of AGM
20th Nov 20237:00 amRNSAGM Trading Update
25th Oct 202310:22 amRNSTermination of ‘upside sharing’ mechanism
19th Oct 20237:00 amRNSTrading Update
17th Oct 20235:42 pmRNSPosting of ARA and Notice of AGM
4th Oct 20235:24 pmRNSVesting of RSU Awards
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20235:33 pmRNSDirector/PDMR Shareholding
21st Sep 202310:54 amRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
14th Jul 20237:00 amRNSFull year trading update
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20235:31 pmRNSDirectorate Change
25th May 20239:38 amRNSDirector Declaration
2nd May 20237:00 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSTrading Update
11th Apr 20232:08 pmRNSDirector/PDMR Shareholding
3rd Apr 20232:39 pmRNSDirector/PDMR Shareholding
31st Mar 202312:27 pmRNSDirector/PDMR Shareholding
21st Mar 20235:59 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSHalf-year Report
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20238:46 amRNSDirector Declaration
17th Jan 20237:00 amRNSTrading Update
11th Jan 20239:01 amRNSDirector Declaration
22nd Dec 20224:23 pmRNSDirector/PDMR Shareholding
13th Dec 20222:51 pmRNSDirector/PDMR Shareholding
16th Nov 20224:42 pmRNSAGM Statement
16th Nov 20227:00 amRNSAGM Trading Update
17th Oct 20227:00 amRNSAnnual Report 2022 and Annual General Meeting 2022
5th Oct 20225:55 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:07 pmRNSRedemption of B Shares
29th Sep 202212:49 pmRNSFinal Results
29th Sep 202211:51 amRNSAmended Financing Agreement
29th Sep 20227:00 amRNSPreliminary results timing
6th Sep 20222:51 pmRNSBoard Update
30th Aug 20224:35 pmRNSPrice Monitoring Extension
25th Aug 20226:22 pmRNSCorrection - Result of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.